GlassScriptPhysician profile
David Blake Minor
NPI 1285610402
$2,298.98
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $453 · 2021: $368 · 2022: $538 · 2023: $43.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $290.63 | 2019-2023 | |
| Janssen Biotech, INC. | $286.50 | 2019-2022 | |
| Abbvie INC. | $279.57 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $267.01 | 2019-2022 | |
| Pfizer INC. | $157.81 | 2019-2021 | |
| Lilly USA, LLC | $150.97 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $106.33 | 2019-2021 | |
| Ucb, INC. | $99.53 | 2019-2022 | |
| Amgen INC. | $76.01 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $73.41 | 2019-2020 | |
| Genzyme Corporation | $68.88 | 2019-2022 | |
| Galderma Laboratories, L.P. | $64.59 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $48.36 | 2019-2021 | |
| Prugen, INC. Pharmaceuticals | $46.85 | 2019 | |
| Allergan, INC. | $45.24 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $44.49 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $40.81 | 2022-2023 | Sotyktu |
| Vyne Pharmaceuticals INC. | $32.38 | 2020 | |
| Sandoz INC. | $30.51 | 2020 | |
| Almirall LLC | $22.72 | 2022 | |
| Celgene Corporation | $19.61 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.43 | 2022 | |
| Dermira, INC. | $15.33 | 2020 | |
| Genentech USA, INC. | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Minor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.